Your browser doesn't support javascript.
Containment of COVID-19: Simulating the impact of different policies and testing capacities for contact tracing, testing, and isolation.
Fiore, Vincenzo G; DeFelice, Nicholas; Glicksberg, Benjamin S; Perl, Ofer; Shuster, Anastasia; Kulkarni, Kaustubh; O'Brien, Madeline; Pisauro, M Andrea; Chung, Dongil; Gu, Xiaosi.
  • Fiore VG; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • DeFelice N; Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Glicksberg BS; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Perl O; Icahn School of Medicine at Mount Sinai, Hasso Plattner Institute for Digital Health at Mount Sinai, New York, New York, United States of America.
  • Shuster A; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Kulkarni K; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • O'Brien M; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Pisauro MA; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
  • Chung D; Department of Experimental Psychology, Wellcome Centre for Integrative Neuroimaging, University of Oxford, Oxford, United Kingdom.
  • Gu X; Centre for Human Brain Health, University of Birmingham, School of Psychology, Birmingham, United Kingdom.
PLoS One ; 16(3): e0247614, 2021.
Article in English | MEDLINE | ID: covidwho-1167062
ABSTRACT
Efficient contact tracing and testing are fundamental tools to contain the transmission of SARS-CoV-2. We used multi-agent simulations to estimate the daily testing capacity required to find and isolate a number of infected agents sufficient to break the chain of transmission of SARS-CoV-2, so decreasing the risk of new waves of infections. Depending on the non-pharmaceutical mitigation policies in place, the size of secondary infection clusters allowed or the percentage of asymptomatic and paucisymptomatic (i.e., subclinical) infections, we estimated that the daily testing capacity required to contain the disease varies between 0.7 and 9.1 tests per thousand agents in the population. However, we also found that if contact tracing and testing efficacy dropped below 60% (e.g. due to false negatives or reduced tracing capability), the number of new daily infections did not always decrease and could even increase exponentially, irrespective of the testing capacity. Under these conditions, we show that population-level information about geographical distribution and travel behaviour could inform sampling policies to aid a successful containment, while avoiding concerns about government-controlled mass surveillance.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Quarantine / Models, Statistical / Contact Tracing / Policy / COVID-19 Testing / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Journal.pone.0247614

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Quarantine / Models, Statistical / Contact Tracing / Policy / COVID-19 Testing / COVID-19 Type of study: Diagnostic study / Experimental Studies / Observational study / Prognostic study Limits: Humans Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Journal.pone.0247614